Connecting high-growth companies with the right healthcare investors.
To deliver superior results, we onboard a maximum of 8 strategic partners per quarter.
We help healthcare companies eliminate months of fundraising hurdles by connecting them with aligned institutional investors and strategic partners—by ticket size, interest and deep industry expertise—within 21 days. Our partners and strategic advisors have raised $250M in healthcare.
Before, we worked with investment bankers who provided a list of 100 contacts but nothing happened. Within a short time working with Apex, we had close to 20 aligned investor meetings. Their filtering process ensures we meet with the right people, making a real difference
Founder of Tempramed
“Before Apex, we were stuck in a spray-and-pray approach with little response. After partnering with them, we shifted to a targeted, automated system, and meetings with aligned investors started appearing on my calendar. We secured 15-20 meetings, with most leading to productive conversations and follow-ups—a massive improvement. Apex made the process effortless and efficient.”
CEO, Nightware
“we struggled to secure investor meetings despite hiring an investment bank with a large network. In just the first week, your team lined up more leads than we had in five months, providing us with unmatched speed and efficiency. Your cookie-cutter, methodical approach and ability to handle everything from start to finish truly set you apart. We’ve already seen significant momentum, with several investors exploring our data room within the first month.”
Founder and CEO, BlueStar Telehealth
“After three months with another firm and no VC meetings, we were frustrated by the misalignment in investor fit. Apex Ascension changed everything. In just more than a week, they secured 14 meetings with perfectly aligned investors in terms of ticket size and interest. “
CEO, Kannact Health & Starlight
Before working with you, I tried multiple firms that took retainers but produced no results. You’re the only one who set us up with quality meetings, leading to 17 investor calls and several NDAs. I appreciate your energy and proactive approach—you’re hungry and driven, which sets you apart. I would give you the highest recommendation.
Founder of Ontheline
Before, we worked with investment bankers who provided a list of 100 contacts but nothing happened. Within a short time working with Apex, we had close to 20 aligned investor meetings. Their filtering process ensures we meet with the right people, making a real difference
Founder of Tempramed
“Before Apex, we were stuck in a spray-and-pray approach with little response. After partnering with them, we shifted to a targeted, automated system, and meetings with aligned investors started appearing on my calendar. We secured 15-20 meetings, with most leading to productive conversations and follow-ups—a massive improvement. Apex made the process effortless and efficient.”
CEO, Nightware
“we struggled to secure investor meetings despite hiring an investment bank with a large network. In just the first week, your team lined up more leads than we had in five months, providing us with unmatched speed and efficiency. Your cookie-cutter, methodical approach and ability to handle everything from start to finish truly set you apart. We’ve already seen significant momentum, with several investors exploring our data room within the first month.”
Founder and CEO, BlueStar Telehealth
“After three months with another firm and no VC meetings, we were frustrated by the misalignment in investor fit. Apex Ascension changed everything. In just more than a week, they secured 14 meetings with perfectly aligned investors in terms of ticket size and interest. “
CEO, Kannact Health & Starlight
These are sophisticated entities such as banks, insurance firms, and pension funds, characterized by their substantial capital base and rigorous investment protocols. Institutional investors prioritize stable, long-term returns and typically engage in diversified investment portfolios.
These are sophisticated entities such as banks, insurance firms, and pension funds, characterized by their substantial capital base and rigorous investment protocols. Institutional investors prioritize stable, long-term returns and typically engage in diversified investment portfolios.
HNWIs, distinguished by their considerable wealth, actively engage in direct investments, particularly in nascent ventures, as angel investors. Apart from financial backing, they offer valuable expertise, networks, and mentorship. HNWIs and angels seek opportunities that align with their risk appetite and strategic interests.
Phase 5 focuses on deal closure by establishing a comprehensive data room, minimizing hold-ups during due diligence, and expediting the overall process.
Our attention to detail ensures completeness and accessibility of documentation, addressing investor concerns preemptively to facilitate a smooth and efficient closure.
Using proprietary technology and extensive networks, we identify and segment investors based on investment stage, valuation, and industry specialization. This approach ensures a curated list of mandate-specific investors tailored to healthcare companies, including medtech, biotech, and health IT.
Our precise targeting enhances outreach effectiveness and secures strong investor commitments.
In Phase 2, we develop and refine all marketing materials, including presentation decks and video presentations, to effectively communicate the value proposition to investors.
We focus on concise messaging, visual aids, and storytelling techniques to enhance engagement and understanding.
Utilizing online channels for distribution amplifies visibility and reach, ensuring that healthcare companies connect with the right investors.
Phase 3 focuses on leveraging existing networks and strategic outreach to connect with potential investors. This includes private server email campaigns, personalized outreach, and content optimization.
We also expand reach through Linkedin campaigns and targeted outreach to ensure engagement with relevant investors, maximizing opportunities for successful connections.
Phase 4 emphasizes building on introductions by conducting pre-meeting due diligence on investors, assigning an analyst to introductory calls, and refining materials and communication based on prospect feedback and initial conversations.
This ensures a tailored approach, maximizing the potential for successful engagement and progression toward investment agreements.
Phase 5 focuses on deal closure by establishing a comprehensive data room, minimizing hold-ups during due diligence, and expediting the overall process.
Our attention to detail ensures completeness and accessibility of documentation, addressing investor concerns preemptively to facilitate a smooth and efficient closure.
Using proprietary technology and extensive networks, we identify and segment investors based on investment stage, valuation, and industry specialization. This approach ensures a curated list of mandate-specific investors tailored to healthcare companies, including medtech, biotech, and health IT.
Our precise targeting enhances outreach effectiveness and secures strong investor commitments.
Managing Partner
Investment Director
Outbound Director
Strategic Advisor
Unlock Innovative Access to Global Capital with Direct Channels to Over 10 Million Institutional, Accredited Retail, and Angel Investors
2024 Apex Ascension Inc. All Rights Reserved.
Burlington, Ontario, Canada – L7T3R1